Safety and immunogenicity of a broad-spectrum mosaic vaccine as a booster dose against SARS-CoV-2 Omicron and other circulating variants
Nawal Al Kaabi, Yun Kai Yang, Yu Liang, Ke Xu, Xue Feng Zhang, Yun Kang, Yu Qin Jin, Jun Wei Hou, Jing Zhang, Tian Yang, Salah Hussein, Mohamed Saif ElDein, Ze Hua Lei, Hao Zhang, Shuai Shao, Zhao Ming Liu, Ning Liu, Xiang Zheng, Ji Guo Su, Sen Sen Yang, Xiangfeng Cong, Yao Tan, Wenwen Lei, Xue Jun Gao, Zhiwei Jiang, Hui Wang, Meng Li, Hanadi Mekki Mekki, Walid Zaher, Sally Mahmoud, Xue Zhang, Chang Qu, Dan Ying Liu, Jing Zhang, Mengjie Yang, Islam Eltantawy, Peng Xiao, Fu Jie Shen, Jin Juan Wu, Zi Bo Han, Li Fang Du, Fang Tang, Shi Chen, Zhi Jing Ma, Fan Zheng, Ya Nan Hou, Xin Yu Li, Xin Li, Zhao Nian Wang, Jin Liang Yin, Xiao Yan Mao, Jin Zhang, Liang Qu, Yun Tao Zhang, Xiao Ming Yang, Guizhen Wu, Qi Ming Li
doi: https://doi.org/10.1101/2022.09.05.22279589
Nawal Al Kaabi
1Sheikh Khalifa Medical City, SEHA, Abu Dhabi, United Arab Emirates
2College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates
Yun Kai Yang
3China National Biotec Group Company Limited, Beijing, China
Yu Liang
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Ke Xu
6National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China
Xue Feng Zhang
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Yun Kang
5National Engineering Center for New Vaccine Research, Beijing, China
7Clinical Medicine Office, National Vaccine and Serum Institute (NVSI), Beijing, China
Yu Qin Jin
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Jun Wei Hou
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Jing Zhang
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Tian Yang
3China National Biotec Group Company Limited, Beijing, China
Salah Hussein
1Sheikh Khalifa Medical City, SEHA, Abu Dhabi, United Arab Emirates
Mohamed Saif ElDein
1Sheikh Khalifa Medical City, SEHA, Abu Dhabi, United Arab Emirates
Ze Hua Lei
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Hao Zhang
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Shuai Shao
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Zhao Ming Liu
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Ning Liu
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Xiang Zheng
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Ji Guo Su
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Sen Sen Yang
5National Engineering Center for New Vaccine Research, Beijing, China
7Clinical Medicine Office, National Vaccine and Serum Institute (NVSI), Beijing, China
Xiangfeng Cong
5National Engineering Center for New Vaccine Research, Beijing, China
7Clinical Medicine Office, National Vaccine and Serum Institute (NVSI), Beijing, China
Yao Tan
5National Engineering Center for New Vaccine Research, Beijing, China
7Clinical Medicine Office, National Vaccine and Serum Institute (NVSI), Beijing, China
Wenwen Lei
6National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China
Xue Jun Gao
8Lanzhou Institute of Biological Products Company Limited, Lanzhou, China
Zhiwei Jiang
9Beijing Key Tech Statistical Consulting Co., Ltd, Beijing, China
Hui Wang
10Beijing Institute of Biological Products Company Limited, Beijing, China
Meng Li
3China National Biotec Group Company Limited, Beijing, China
Hanadi Mekki Mekki
11Union 71, United Arab Emirates
Walid Zaher
12G42 Healthcare, United Arab Emirates
Sally Mahmoud
12G42 Healthcare, United Arab Emirates
Xue Zhang
3China National Biotec Group Company Limited, Beijing, China
Chang Qu
3China National Biotec Group Company Limited, Beijing, China
Dan Ying Liu
3China National Biotec Group Company Limited, Beijing, China
Jing Zhang
6National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China
Mengjie Yang
6National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China
Islam Eltantawy
12G42 Healthcare, United Arab Emirates
Peng Xiao
12G42 Healthcare, United Arab Emirates
Fu Jie Shen
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Jin Juan Wu
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Zi Bo Han
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Li Fang Du
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Fang Tang
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Shi Chen
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Zhi Jing Ma
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Fan Zheng
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Ya Nan Hou
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Xin Yu Li
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Xin Li
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Zhao Nian Wang
3China National Biotec Group Company Limited, Beijing, China
Jin Liang Yin
3China National Biotec Group Company Limited, Beijing, China
Xiao Yan Mao
8Lanzhou Institute of Biological Products Company Limited, Lanzhou, China
Jin Zhang
10Beijing Institute of Biological Products Company Limited, Beijing, China
Liang Qu
3China National Biotec Group Company Limited, Beijing, China
Yun Tao Zhang
3China National Biotec Group Company Limited, Beijing, China
Xiao Ming Yang
3China National Biotec Group Company Limited, Beijing, China
Guizhen Wu
6National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China
Qi Ming Li
4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
5National Engineering Center for New Vaccine Research, Beijing, China
Article Information
History
- September 6, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nawal Al Kaabi1,2,13,
- Yun Kai Yang3,13,
- Yu Liang4,5,13,
- Ke Xu6,13,
- Xue Feng Zhang4,5,
- Yun Kang5,7,
- Yu Qin Jin4,5,
- Jun Wei Hou4,5,
- Jing Zhang4,5,
- Tian Yang3,
- Salah Hussein1,
- Mohamed Saif ElDein1,
- Ze Hua Lei4,5,
- Hao Zhang4,5,
- Shuai Shao4,5,
- Zhao Ming Liu4,5,
- Ning Liu4,5,
- Xiang Zheng4,5,
- Ji Guo Su4,5,
- Sen Sen Yang5,7,
- Xiangfeng Cong5,7,
- Yao Tan5,7,
- Wenwen Lei6,
- Xue Jun Gao8,
- Zhiwei Jiang9,
- Hui Wang10,
- Meng Li3,
- Hanadi Mekki Mekki11,
- Walid Zaher12,
- Sally Mahmoud12,
- Xue Zhang3,
- Chang Qu3,
- Dan Ying Liu3,
- Jing Zhang6,
- Mengjie Yang6,
- Islam Eltantawy12,
- Peng Xiao12,
- Fu Jie Shen4,5,
- Jin Juan Wu4,5,
- Zi Bo Han4,5,
- Li Fang Du4,5,
- Fang Tang4,5,
- Shi Chen4,5,
- Zhi Jing Ma4,5,
- Fan Zheng4,5,
- Ya Nan Hou4,5,
- Xin Yu Li4,5,
- Xin Li4,5,
- Zhao Nian Wang3,
- Jin Liang Yin3,
- Xiao Yan Mao8,
- Jin Zhang10,
- Liang Qu3,
- Yun Tao Zhang3,✉,
- Xiao Ming Yang3,✉,
- Guizhen Wu6,✉ and
- Qi Ming Li4,5,✉,*
- 1Sheikh Khalifa Medical City, SEHA, Abu Dhabi, United Arab Emirates
- 2College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates
- 3China National Biotec Group Company Limited, Beijing, China
- 4The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China
- 5National Engineering Center for New Vaccine Research, Beijing, China
- 6National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China
- 7Clinical Medicine Office, National Vaccine and Serum Institute (NVSI), Beijing, China
- 8Lanzhou Institute of Biological Products Company Limited, Lanzhou, China
- 9Beijing Key Tech Statistical Consulting Co., Ltd, Beijing, China
- 10Beijing Institute of Biological Products Company Limited, Beijing, China
- 11Union 71, United Arab Emirates
- 12G42 Healthcare, United Arab Emirates
- ↵* Corresponding author; email: liqiming189{at}163.com
↵13 These authors contributed equally: Nawal Al Kaabi, Yun Kai Yang, Yu Liang, Ke Xu.
Posted September 06, 2022.
Safety and immunogenicity of a broad-spectrum mosaic vaccine as a booster dose against SARS-CoV-2 Omicron and other circulating variants
Nawal Al Kaabi, Yun Kai Yang, Yu Liang, Ke Xu, Xue Feng Zhang, Yun Kang, Yu Qin Jin, Jun Wei Hou, Jing Zhang, Tian Yang, Salah Hussein, Mohamed Saif ElDein, Ze Hua Lei, Hao Zhang, Shuai Shao, Zhao Ming Liu, Ning Liu, Xiang Zheng, Ji Guo Su, Sen Sen Yang, Xiangfeng Cong, Yao Tan, Wenwen Lei, Xue Jun Gao, Zhiwei Jiang, Hui Wang, Meng Li, Hanadi Mekki Mekki, Walid Zaher, Sally Mahmoud, Xue Zhang, Chang Qu, Dan Ying Liu, Jing Zhang, Mengjie Yang, Islam Eltantawy, Peng Xiao, Fu Jie Shen, Jin Juan Wu, Zi Bo Han, Li Fang Du, Fang Tang, Shi Chen, Zhi Jing Ma, Fan Zheng, Ya Nan Hou, Xin Yu Li, Xin Li, Zhao Nian Wang, Jin Liang Yin, Xiao Yan Mao, Jin Zhang, Liang Qu, Yun Tao Zhang, Xiao Ming Yang, Guizhen Wu, Qi Ming Li
medRxiv 2022.09.05.22279589; doi: https://doi.org/10.1101/2022.09.05.22279589
Safety and immunogenicity of a broad-spectrum mosaic vaccine as a booster dose against SARS-CoV-2 Omicron and other circulating variants
Nawal Al Kaabi, Yun Kai Yang, Yu Liang, Ke Xu, Xue Feng Zhang, Yun Kang, Yu Qin Jin, Jun Wei Hou, Jing Zhang, Tian Yang, Salah Hussein, Mohamed Saif ElDein, Ze Hua Lei, Hao Zhang, Shuai Shao, Zhao Ming Liu, Ning Liu, Xiang Zheng, Ji Guo Su, Sen Sen Yang, Xiangfeng Cong, Yao Tan, Wenwen Lei, Xue Jun Gao, Zhiwei Jiang, Hui Wang, Meng Li, Hanadi Mekki Mekki, Walid Zaher, Sally Mahmoud, Xue Zhang, Chang Qu, Dan Ying Liu, Jing Zhang, Mengjie Yang, Islam Eltantawy, Peng Xiao, Fu Jie Shen, Jin Juan Wu, Zi Bo Han, Li Fang Du, Fang Tang, Shi Chen, Zhi Jing Ma, Fan Zheng, Ya Nan Hou, Xin Yu Li, Xin Li, Zhao Nian Wang, Jin Liang Yin, Xiao Yan Mao, Jin Zhang, Liang Qu, Yun Tao Zhang, Xiao Ming Yang, Guizhen Wu, Qi Ming Li
medRxiv 2022.09.05.22279589; doi: https://doi.org/10.1101/2022.09.05.22279589
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2930)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12734)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4577)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (424)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4344)
- Nursing (236)
- Nutrition (638)
- Oncology (2266)
- Ophthalmology (645)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6932)
- Radiology and Imaging (1525)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (487)
- Toxicology (60)
- Transplantation (210)
- Urology (180)